Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. Export

@article{citeulike:694783, abstract = {A 38-year-old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full-matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor origin. The patient never achieved a remission even after chemotherapies with cytarabine and mitoxantrone, donor lymphocyte infusion, and second allogeneic peripheral blood stem cell transplantation. Donor cell leukemia (DCL) is sometimes misdiagnosed as relapse by clinicians and the real incidence may be higher than expected. Cytogenetic and molecular techniques may be helpful to clarify the issue of the leukemia. The current case is another case of DCL reported in the literature after an allogeneic transplant for a kind of leukemia.}, address = {Department of Medical Oncology and Bone Marrow Transplantation Unit, Gulhane Faculty of Medicine, Ankara, Turkey.}, author = {Ataergin, S. and Arpaci, F. and Cetin, T. and Guran, S. and Yakicier, C. and Beyzadeoglu, M. and Ozet, A.}, citeulike-article-id = {694783}, citeulike-linkout-0 = {http://dx.doi.org/10.1002/ajh.20615}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/16628734}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=16628734}, doi = {10.1002/ajh.20615}, issn = {0361-8609}, journal = {Am J Hematol}, keywords = {bone, donor, marrow, transmission}, month = {May}, number = {5}, pages = {370--373}, posted-at = {2006-06-13 13:18:01}, priority = {2}, title = {Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.}, url = {http://dx.doi.org/10.1002/ajh.20615}, volume = {81}, year = {2006} }

TY - JOUR ID - citeulike:694783 L3 - citeulike-article-id:694783 N2 - A 38-year-old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full-matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor origin. The patient never achieved a remission even after chemotherapies with cytarabine and mitoxantrone, donor lymphocyte infusion, and second allogeneic peripheral blood stem cell transplantation. Donor cell leukemia (DCL) is sometimes misdiagnosed as relapse by clinicians and the real incidence may be higher than expected. Cytogenetic and molecular techniques may be helpful to clarify the issue of the leukemia. The current case is another case of DCL reported in the literature after an allogeneic transplant for a kind of leukemia. IS - 5 JF - Am J Hematol SN - 0361-8609 AD - Department of Medical Oncology and Bone Marrow Transplantation Unit, Gulhane Faculty of Medicine, Ankara, Turkey. EP - 373 TI - Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. VL - 81 SP - 370 KW - bone KW - donor KW - marrow KW - transmission AU - Ataergin, S AU - Arpaci, F AU - Cetin, T AU - Guran, S AU - Yakicier, C AU - Beyzadeoglu, M AU - Ozet, A PY - 2006/05// UR - http://dx.doi.org/10.1002/ajh.20615 ER -